Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC)

2014 ◽  
Vol 90 (5) ◽  
pp. S37 ◽  
Author(s):  
F.R. Hirsch ◽  
R. Govindan ◽  
Z. Zvirbule ◽  
F. Braiteh ◽  
A. Rittmeyer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Controlled Study ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
First Line ◽  
Doublet Chemotherapy ◽  
Platinum Doublet

Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study

Lung Cancer ◽  
2015 ◽  
Vol 90 (3) ◽  
pp. 427-432 ◽  
Author(s):  
Denis Moro-Sibilot ◽  
Egbert Smit ◽  
Javier de Castro Carpeño ◽  
Krzysztof Lesniewski-Kmak ◽  
Joachim G. Aerts ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Doublet Chemotherapy ◽  
Platinum Doublet
Sign in / Sign up

Export Citation Format

Share Document